Gold GORO Q4 2025 Results Meet Expectations Revenue NA Taiwan Arms Sales Emerge as Central Issue in TrumpXi Talks Gladstone GOOD Stock Up 092 Key Resistance at 1320 20260520 Kymera Therapeutics KYMR Holds Steady Near 80 as Key Levels Come into Focus